Fig. 2From: Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancersHigh level of TRPM7 leads to poor prognosis of breast cancer patients. Expression of TRPM7 gene causes shorter survival times after surgery especially in the Lumina A subtypeBack to article page